Antibody responses to natural SARS-CoV-2 infection or after COVID-19 vaccination

H Altawalah - Vaccines, 2021 - mdpi.com
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …

Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study

H Altawalah, F AlHuraish, WA Alkandari… - Journal of Clinical …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2) and represents a global pandemic affecting more …

In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic …

KS Ebrahimi, M Ansari, MSH Moghaddam… - Computers in biology …, 2021 - Elsevier
Abstract The newly emerged Coronavirus Disease 2019 (COVID-19) rapidly outspread
worldwide and now is one of the biggest infectious pandemics in human society. In this …

Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy

U Saeed, SR Uppal, ZZ Piracha, A Rasheed, Z Aftab… - Virology Journal, 2021 - Springer
Rapid diagnosis of SARS-CoV-2 during pandemic enables timely treatment and prevention
of COVID-19. Evaluating the accuracy and reliability of rapid diagnostic testing kits is crucial …

Vaccination and antiviral treatment reduce the time to negative SARS-CoV-2 Swab: a real-life study

A De Vito, G Moi, L Saderi, MV Puci, A Colpani, L Firino… - Viruses, 2023 - mdpi.com
Clinical trials demonstrated the role of vaccines and antiviral treatments against SARS-CoV-
2 in reducing the likelihood of disease progression and death. However, there are limited …

Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach

S Mahmud, S Afrose, S Biswas, A Nagata, GK Paul… - PLoS …, 2022 - journals.plos.org
The current coronavirus disease 2019 (COVID-19) pandemic, caused by the coronavirus 2
(SARS-CoV-2), involves severe acute respiratory syndrome and poses unprecedented …

Diagnostic performance of automated SARS-CoV-2 antigen assay in nasal swab during COVID-19 vaccination campaign

H Altawalah, W Alfouzan, T Al-Fadalah, S Ezzikouri - Diagnostics, 2021 - mdpi.com
Background: To control the spread of the pandemic brought about by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it is necessary to have an …

Nanobodies: an unexplored opportunity to combat COVID-19

S Ezzikouri, J Nourlil, K Tsukiyama-Kohara… - Journal of …, 2022 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by
severe acute respiratory coronavirus 2 (SARS-CoV-2). This virus is capable of human-to …

[HTML][HTML] Mix-and-match COVID-19 vaccines trigger high antibody response after the third dose vaccine in Moroccan health care workers

H Amellal, N Assaid, K Akarid, A Maaroufi, S Ezzikouri… - Vaccine: X, 2023 - Elsevier
Recent studies have shown that in individuals who have received two doses of COVID-19
vaccine, the level of IgG antibodies decreased over time. In addition, the resurgence of the …

Antibody response to SARS-CoV-2 infection and vaccination in COVID-19-naïve and experienced individuals

SL Uprichard, A O'Brien, M Evdokimova, CL Rowe… - Viruses, 2022 - mdpi.com
Understanding the magnitude of responses to vaccination during the ongoing SARS-CoV-2
pandemic is essential for ultimate mitigation of the disease. Here, we describe a cohort of …